Polymorphisms in <i>CPT1B</i> and <i>CPT2</i> have no significant effect on plasma carnitine levels in Japanese cancer patients.

Hishida, Asahi; Watanabe, Ryosuke; Hattori, Yuta; Okugawa, Yoshinaga; Shirai, Yumiko; Miki, Chikao

Polymorphisms in CPT1B and CPT2 have no significant effect on plasma carnitine levels in Japanese cancer patients.

Hishida, Asahi; Watanabe, Ryosuke; Hattori, Yuta; Okugawa, Yoshinaga; Shirai, Yumiko; Miki, Chikao.

Afiliación

Hishida A; Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Watanabe R; Nagoya University School of Medicine, Nagoya, Japan.
Hattori Y; Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Okugawa Y; Surgery, Iga City General Hospital, Mie, Japan.
Shirai Y; Nutrition, Iga City General Hospital, Mie, Japan.
Miki C; Surgery, Iga City General Hospital, Mie, Japan.

Nagoya J Med Sci ; 81(3): 477-487, 2019 Aug.

Article en En | MEDLINE | ID: mdl-31579338

Asunto(s)

Carnitina O-Palmitoiltransferasa/genética; Carnitina O-Palmitoiltransferasa/metabolismo; Carnitina/sangre; Neoplasias/genética; Polimorfismo Genético/genética; Genotipo; Humanos; Neoplasias/metabolismo

Palabras clave

CPT1B; CPT2; cancer palliative care; carnitine; genetic polymorphisms

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Carnitina / Carnitina O-Palmitoiltransferasa / Neoplasias Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Nagoya J Med Sci Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google